Press Release

Press Release | Apr 26, 2018

Genoptix, Inc., a leading oncology diagnostic laboratory today announced that Rosetta Genomics’ stockholders have approved the acquisition of Rosetta Genomics by Genoptix. Genoptix will immediately begin marketing, selling and distributing the complete Rosetta Genomics portfolio and will ensure the uninterrupted availability of these important products for physicians and patients. Genoptix previously purchased Rosetta Genomics’ precision

Press Release | Feb 01, 2018

Colorescience®, the leading dermatologist-recommended skin health-focused skincare and cosmetics company, is proud to introduce the innovative Colorescience Total Eye™ 3-in-1 Renewal Therapy SPF 35. This comprehensive eye product is a strong addition to the brand’s treatment portfolio that includes All Calm™ Clinical Redness Corrector SPF 50, which addresses symptoms of adult acne and rosacea, and

Press Release | Dec 15, 2017

Genoptix, Inc., a leading oncology diagnostic laboratory, and Rosetta Genomics Ltd. (ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and accurate diagnostic information to physicians, jointly announce that they have entered into a definitive merger agreement under which Genoptix will acquire all of the outstanding shares of Rosetta Genomics for a

Press Release | Sep 27, 2017

Onkos Surgical, Inc., a specialty medtech company dedicated to advancing innovation for the surgical oncology market announced today that it will launch a new service platform focused on preoperative surgical planning called Precision Oncology. The company will showcase the new platform at the upcoming Musculoskeletal Tumor Society (MSTS) held in Denver, Colorado.

Pages 1 2 3 4 5 6